Department of Medical Ultrasound, Third People's Hospital of Nantong University & Nantong Third People's Hospital, Nantong, China.
Department of Medical Ultrasound, Shanghai Tenth People's Hospital, Ultrasound Research and Education Institute, Tongji University School of Medicine, Shanghai, China.
Clin Hemorheol Microcirc. 2019;71(4):483-498. doi: 10.3233/CH-180431.
To retrospectively evaluate the role of intraoperative ultrasonography (IOUS) and contrast-enhanced IOUS (CE-IOUS) for the patients with hepatocellular carcinoma (HCC) undergoing hepatic resection (HR).
Twenty-one consecutive patients who had undergone HR for HCC were included in this study. The patients were subject to preoperative imaging modalities including preoperative ultrasonography (Pre-US) and preoperative contrast-enhanced ultrasonography (Pre-CEUS). All the patients then underwent intraoperative ultrasonography (IOUS) and contrast-enhanced intraoperative ultrasonography (CE-IOUS) during surgery. The visualization of primary HCC and additional lesions of all patients were analyzed.
Twenty-one HCCs were detected during Pre-US and the remaining six lesions (28.6%) were detected during IOUS and CE-IOUS. Thus the treatment plan was changed in 28.6% of patients. Twenty-one HCCs (diameter, 0.6-3.0 cm; mean±SD, 1.98±0.85 cm) were measured on Pre-US and remeasured on IOUS (diameter, 0.9-3.3 cm; mean±SD, 2.19±0.84 cm) (p < 0.001). The 6 additional lesions consisted of three moderately differentiated HCCs, one cholangiocarcinoma (ICC), and two high-grade dysplastic nodules (DNs). The mean maximal diameter of the 6 additional lesions was 0.83 cm (range: 0.6-1.1 cm). The malignancy associated features such as capsule interruption, echo heterogeneity, hypo-echoic rim, and a nodule in nodule pattern were more often depicted on IOUS than on Pre-US (all p < 0.01). On CEUS, 19 (90.5%) of 21 HCCs were hyper-enhanced in the arterial phase and washed out from the portal phase to the late phase; the remaining two (9.5%) were hypoenhanced. On CE-IOUS, tumor vasculatures were classified as four patterns: 11 (52.4%) exhibited netlike pattern, 7 (33.3%) annular pattern, 2 (9.5%) mixed pattern, and 1 (4.8%) radial pattern. 3 mHCCs and 2 DNs of six additional nodules had similar greyscale imagining features on IOUS, but they showed different enhancement patterns on CE-IOUS. The ICC showed slightly heterogeneous enhancement during the arterial phase and hypo-enhancement during the portal phase.
IOUS detects more lesions and the treatment plan is changed in 28.6% of patients. HCCs were larger on IOUS than on Pre-US. The typical imaging features of HCCs were better depicted on IOUS in comparison with Pre-US. CE-IOUS can catch the details of microcirculation perfusion of HCCs more sensitively than CEUS. Both IOUS and CE-IOUS were able to provide more decision information during surgery.
回顾性评估术中超声(IOUS)和对比增强术中超声(CE-IOUS)在接受肝切除术(HR)的肝细胞癌(HCC)患者中的作用。
本研究纳入了 21 例连续接受 HCC HR 的患者。这些患者接受了术前影像学检查,包括术前超声(Pre-US)和术前对比增强超声(Pre-CEUS)。所有患者在手术期间均接受了术中超声(IOUS)和对比增强术中超声(CE-IOUS)。分析所有患者原发性 HCC 和其他病变的可视化情况。
Pre-US 检测到 21 个 HCC,IOUS 和 CE-IOUS 检测到另外 6 个病变(28.6%)。因此,28.6%的患者改变了治疗计划。Pre-US 检测到的 21 个 HCC(直径 0.6-3.0cm;平均值±标准差,1.98±0.85cm)在 IOUS 上重新测量(直径 0.9-3.3cm;平均值±标准差,2.19±0.84cm)(p<0.001)。6 个附加病变包括 3 个中分化 HCC、1 个胆管癌(ICC)和 2 个高级别异型增生结节(DN)。6 个附加病变的平均最大直径为 0.83cm(范围:0.6-1.1cm)。IOUS 比 Pre-US 更常显示与恶性相关的特征,如包膜中断、回声异质性、低回声环和结节内结节模式(均 p<0.01)。CEUS 上,21 个 HCC 中有 19 个(90.5%)在动脉期呈高增强,从门静脉期到晚期呈洗脱;其余两个(9.5%)呈低增强。在 CE-IOUS 上,肿瘤血管分为 4 种模式:11 个(52.4%)呈网状模式,7 个(33.3%)呈环状模式,2 个(9.5%)呈混合模式,1 个(4.8%)呈放射状模式。6 个附加结节中的 3 个 mHCC 和 2 个 DNs 在 IOUS 上具有相似的灰度成像特征,但在 CE-IOUS 上显示出不同的增强模式。ICC 在动脉期呈轻度异质性增强,门静脉期呈低增强。
IOUS 检测到更多病变,并改变了 28.6%的患者的治疗计划。IOUS 上 HCC 比 Pre-US 上的 HCC 更大。与 Pre-US 相比,IOUS 更好地显示了 HCC 的典型影像学特征。CE-IOUS 比 CEUS 更能敏感地捕捉 HCC 微循环灌注的细节。IOUS 和 CE-IOUS 均可在手术期间提供更多决策信息。